Canadian Journal of Infectious Diseases and Medical Microbiology

Canadian Journal of Infectious Diseases and Medical Microbiology / 1992 / Article

Open Access

Volume 3 |Article ID 895087 | https://doi.org/10.1155/1992/895087

William R Greco, Wlodzimierz E Dembinski, "Fundamental Concepts in the Assessment of Interaction of Biological Response Modifiers with other Agents", Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 3, Article ID 895087, 9 pages, 1992. https://doi.org/10.1155/1992/895087

Fundamental Concepts in the Assessment of Interaction of Biological Response Modifiers with other Agents

Abstract

The universal response surface approach (URSA) was developed to assess the nature and intensity of drug interactions, ie, synergism. antagonism and additivity. URSA consists of fitting a concentration-effect surface to experimental data with maximum likelihood approaches, with the estimation of parameters, including: ID5os, concentration-effect slopes and the synergism-antagonism parameter α When α is positive, synergism is indicated, when α is negative, antagonism is indicated and when α is zero. additivity is indicated. URSA was applied to data from a set of 45 in vitro growth inhibition experiments with the L929 mouse cell line. The cytokine, tumour necrosis factor (TNF), was combined with one of nine eicosanoid synthesis inhibitors: indomethacin, Ro 20-5720, ibuprofen (cyclooxygenase inhibitors): nordihydroguaiaretic acid, nafazatrom, esculetin (lipoxygenase inhibitors): or BW-755C, p henidone, timegadine [cyclo- and lipoxygenase inhibitors). Five different schedules were used with various orders and durations of drug exposure. Examples of all three types of drug interaction were found for combinations of TNF with all three classes of drugs. The largest synergism found was for TNF plus BW-755C (α = 4.30±1.3 [SE]). In general, for each combination, the degree of synergism was greater for schedules in which cells were exposed to TNF before exposure to the other agent.

Copyright © 1992 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views47
Downloads185
Citations

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.